NCT05016817View on ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 3, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (1)

Unknown

RECRUITING

Medical Surgical Associates Center, St John's

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER